Sana Biotechnology, Inc. (NASDAQ: SANA), a company focused on changing the possible for patients through engineered cells, today announced that it has sold an aggregate of 21,607,878 shares of the ...
Brazil’s sugar powerhouse shows what Europe is missing in biofuel aspirations, Irish Examiner Farming editor Rachel Martin ...
From Genryo’s Sidewinder technology to the Festival of Genomics & Biodata in the UK earlier this year – AI might be trending, ...
Experts say the name was changed because the previous term, PCOS, focused mainly on ovarian cysts, even though many women ...
A team of engineers at the University of Florida has developed a new form of CRISPR technology that could make diagnostics ...
In Netherlands and Norway, Prime Minister Narendra Modi is applying a quiet but determined strategy towards deepening ...
Recently, ACROBiosystems successfully held its Innovation Day at Superlab Suisse Zürich Schlieren in Zurich, Switzerland, a ...
Other leaders’s accounts and unscripted moments portray a Chinese president with a quick wit, an unshakeable belief in ...
Australian chief executives have hit out at the lack of action on anaemic productivity rates in Jim Chalmers’ budget and the ...
A Purdue University–affiliated startup working to reshape how staple crops are bred has secured new federal funding aimed at ...
AndzonBio2 today announced the signature of agreements with the ALBORADA Drug Discovery Institute (ADDI) at the University of Cambridge and Cambridge Enterprise to advance a new class of therapeutics ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results